Thompson, Sara A J <br/><br/>
B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis.  [electronic resource] 

 -  Journal of clinical immunology  Jan 2010 
 - 99-105 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2592 
<br/><br/><label>Standard No.: </label>10.1007/s10875-009-9327-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Alemtuzumab<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--administration & dosage<br/>B-Cell Activating Factor--biosynthesis<br/>B-Lymphocytes--drug effects<br/>Cell Differentiation--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunologic Memory--drug effects<br/>Immunophenotyping<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--blood<br/>T-Lymphocytes--drug effects